ArticleInternational journal of hematology2020
Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction.
Takeshi Hara et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it